ALKBH5 and plasma cell myeloma: Both in vitro and in vivo studies revealed that ALKBH5-demethylated lncRNA SNHG15 regulates malignant phenotypes of MM, including viability and migration/invasion of MM cells, implying it is a novel and critical myeloma-promoting molecule and might be a potential therapeutic target of MM.